Please use this identifier to cite or link to this item:
http://hdl.handle.net/11054/655
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cole, Justin A. | en |
dc.contributor.author | Brennan, Angela | en |
dc.contributor.author | Ajani, Andrew E. | en |
dc.contributor.author | Yan, Bryan P. | en |
dc.contributor.author | Duffy, Stephen J. | en |
dc.contributor.author | Loane, Philippa | en |
dc.contributor.author | Reid, Christopher M. | en |
dc.contributor.author | Yudi, Matias B. | en |
dc.contributor.author | New, Gishel | en |
dc.contributor.author | Black, Alexander | en |
dc.contributor.author | Shaw, James A. | en |
dc.contributor.author | Clark, David J. | en |
dc.contributor.author | Andrianopoulos, Nick | en |
dc.date.accessioned | 2015-04-27T04:02:18Z | en |
dc.date.available | 2015-04-27T04:02:18Z | en |
dc.date.issued | 2014 | en |
dc.identifier.govdoc | 00637 | en |
dc.identifier.issn | 1755-5922 | en |
dc.identifier.uri | http://hdl.handle.net/11054/655 | en |
dc.description.abstract | This article includes data from Ballarat Health Services. Aims: Despite the guidelines, a “treatment gap” exists in the delivery of pharmacotherapy for secondary prevention. We aimed to analyze the trend in guideline-based medication usage following percutaneous coronary intervention (PCI) using the Melbourne Interventional Group (MIG) registry over a 6-year period (2005–2010). Methods: The MIG registry prospectively collects demographical, clinical, and procedural characteristics of consecutive patients undergoing PCI. We assessed medication use (aspirin, clopidogrel, ACE inhibitors, angiotensin receptor blockers, beta-blockers, and lipid-lowering agents) at 30 days and 12 months in patients alive and able to provide the information. Results: The cohort consists of 12,813 patients who underwent 14,787 consecutive interventional procedures. They comprised 76% males: 22% were elderly (≥75 years), 23% had diabetes, 2% had severe renal impairment, 2% had severe left ventricular dysfunction, 26% presented with STEMI, and 44% of patients received drug-eluting stent. Follow-up was complete for 97.8% of the cohort at 30 days (2.2% mortality) and 89.1% at 12 months (4% mortality). From 2005 to 2010, the percentage of patients taking all five classes of medications increased each year. In 2010 at 30 days, nearly 60% of patients took all five classes of medications, and by 12 months, 75% of patients were taking four or five classes of medications. Conclusion: In conclusion, while the increasing use of cardiovascular medicines in an “at-risk” Australian cohort is encouraging, a treatment gap appears to still exist. | en |
dc.description.provenance | Submitted by Gemma Siemensma (gemmas@bhs.org.au) on 2015-04-27T04:01:46ZNo. of bitstreams: 0 | en |
dc.description.provenance | Approved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2015-04-27T04:02:18Z (GMT) No. of bitstreams: 0 | en |
dc.description.provenance | Made available in DSpace on 2015-04-27T04:02:18Z (GMT). No. of bitstreams: 0 Previous issue date: 2014 | en |
dc.publisher | Wiley | en |
dc.relation.uri | http://onlinelibrary.wiley.com/doi/10.1111/1755-5922.12060/full | en |
dc.title | Cardiovascular medication use following percutaneous coronary intervention: the Australian experience. | en |
dc.type | Journal Article | en |
dc.type.specified | Article | en |
dc.bibliographicCitation.title | Cardiovascular Therapeutics | en |
dc.bibliographicCitation.volume | 32 | en |
dc.bibliographicCitation.issue | 2 | en |
dc.bibliographicCitation.stpage | 47 | en |
dc.bibliographicCitation.endpage | 51 | en |
dc.subject.healththesaurus | GUIDELINES | en |
dc.subject.healththesaurus | MEDICATIONS | en |
dc.subject.healththesaurus | PCI | en |
dc.subject.healththesaurus | PERCUTANEOUS CORONARY INTERVENTION | en |
dc.subject.healththesaurus | REGISTRY | en |
dc.subject.healththesaurus | PHARMACOTHERAPY | en |
dc.date.issuedbrowse | 2014-01-01 | en |
Appears in Collections: | Research Output |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.